Page 86 - 《中国药房》2023年15期

[ 4 ] LOPES T Z，DE MORAES F R，TEDESCO A C，et al. [11] LI S Y，SHI C J，FU W M，et al. Berberine inhibits tumour
Berberine associated photodynamic therapy promotes au‐ growth in vivo and in vitro through suppressing the
tophagy and apoptosis via ROS generation in renal carci‐ lincROR-Wnt/β-catenin regulatory axis in colorectal can‐
noma cells[J]. Biomedecine Pharmacother，2020，123： cer[J]. J Pharm Pharmacol，2023，75（1）：129-138.
109794. [12] ZHAO M Y，YANG Y，NIAN Q，et al. Phytochemicals
[ 5 ] ZHAO Z Y，ZENG J H，GUO Q，et al. Berberine sup‐ and mitochondria：therapeutic allies against gastric cancer
presses stemness and tumorigenicity of colorectal cancer [J]. Phytomedicine，2023，110：154608.
stem-like cells by inhibiting m6A methylation[J]. Front [13] SKONIECZNA M， ADAMIEC-ORGANISCIOK M，
Oncol，2021，11：775418. HUDY D，et al. Hepatocellular cancer cell lines，Hep-3B
[ 6 ] CAI J R，YANG F，ZHAN H L，et al. RNA m6A methyl‐ and Hep-G2 display the pleiotropic response to resveratrol
transferase METTL3 promotes the growth of prostate can‐ and berberine[J]. Adv Med Sci，2022，67（2）：379-385.
cer by regulating hedgehog pathway[J]. Onco Targets [14] WANG Z，ZHOU J，ZHANG H，et al. RNA m（6） A
Ther，2019，12：9143-9152. methylation in cancer[J]. Mol Oncol，2023，17（2）：
[ 7 ] ZHU D W，LIU Y T，CHEN J J，et al. The methyltransfe- 195-229.
rase METTL3 promotes tumorigenesis via mediating [15] LIU S P，LI Q J，CHEN K，et al. The emerging molecular
HHLA2 mRNA m6A modification in human renal cell car‐ mechanism of m6A modulators in tumorigenesis and can‐
cinoma[J]. J Transl Med，2022，20（1）：298. cer progression[J]. Biomedecine Pharmacother，2020，
[ 8 ] GUEVELOU J L，SARGOS P，SIVA S，et al. The emer- 127：110098.
ging role of extracranial stereotactic ablative radiotherapy [16] LIU L，LI H，HU D Y，et al. Insights into N6-methyl‐
for metastatic renal cell carcinoma：a systematic review adenosine and programmed cell death in cancer[J]. Mol
[J]. Eur Urol Focus，2023，9（1）：114-124. Cancer，2022，21（1）：32.
[ 9 ] ALBIGES L，POWLES T，STAEHLER M，et al. Updated [17] CHENG M S，SHENG L，GAO Q，et al. The m6A methyl‐
European Association of Urology guidelines on renal cell transferase METTL3 promotes bladder cancer progression
carcinoma：immune checkpoint inhibition is the new back‐ via AFF4/NF-κB/MYC signaling network[J]. Oncogene，
bone in first-line treatment of metastatic clear-cell renal 2019，38（19）：3667-3680.
cell carcinoma[J]. Eur Urol，2019，76（2）：151-156. [18] ZHAO J X，LU L G. Interplay between RNA methylation
[10] GONG D K，ZHANG J，CHEN Y H，et al. The m6A- eraser FTO and writer METTL3 in renal clear cell carci‐
suppressed P2RX6 activation promotes renal cancer cells noma patient survival[J]. Recent Pat Anticancer Drug Dis‐
migration and invasion through ATP-induced Ca influx cov，2021，16（3）：363-376.
2+
modulating ERK1/2 phosphorylation and MMP9 sig- （收稿日期：2023-01-30 修回日期：2023-06-18）
naling pathway[J]. J Exp Clin Cancer Res，2019，38 （编辑：林 静）
（1）：233.

· 1868 · China Pharmacy 2023 Vol. 34 No. 15 中国药房 2023年第34卷第15期